Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
No case yet. It builds on the next filing, report or 13F period.
Regencell Bioscience Holdings Ltd has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2833, Medicinal Chemicals & Botanical Products, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
High 6.04 at 10:45 am ET, low 5.89 at 3:45 pm ET.
Regencell Bioscience Holdings Ltd
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Medicinal Chemicals & Botanical Products
RGC (Regencell Bioscience Holdings Ltd) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
35 managers report a position worth $9.7M between them, and 6 of them hold 80% of it.